Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Quick-slow compound medicine of anti-tuberculosis

An anti-tuberculosis and drug technology, applied in the direction of antibacterial drugs, pharmaceutical formulas, medical preparations containing active ingredients, etc., to achieve the effect of fast onset time and long residence time in the body

Inactive Publication Date: 2007-05-02
江西万基药物研究院药业有限责任公司
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, most anti-tuberculosis drugs at home and abroad are common preparations, and there is no research report on making the anti-tuberculosis compound rifampicin (rifampicin + isoniazid) into a "fast-slow double-release" preparation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Quick-slow compound medicine of anti-tuberculosis
  • Quick-slow compound medicine of anti-tuberculosis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] Rifampicin 2 servings

[0048] Isoniazid 1 part

[0049] Crospovidone 0.14 parts

[0050] Hydroxypropyl methylcellulose 0.5 parts

[0051] According to the pharmacologically acceptable preparation method, the tablet is made.

Embodiment 2

[0053]Rifampin 2 servings

[0054] Isoniazid 1 part

[0055] 0.14 parts of sodium carboxymethyl starch

[0056] Hydroxypropyl methylcellulose 0.7 parts

[0057] According to the pharmacologically acceptable preparation method, a dry suspension is prepared.

Embodiment 3

[0059] Rifampin 2 servings

[0060] Isoniazid 1 part

[0061] Sodium Croscarmellose 0.13 parts

[0062] 0.52 parts of hydroxypropyl methylcellulose

[0063] According to a pharmacologically acceptable preparation method, a capsule is prepared.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A both fast-release and slow-release compound medicine for preventing and treating tuberculosis (TB) is prepared from rifampin, isoniazid in the ratio of 2:1, and the pharmacologically acceptable auxiliary consisting of skeleton material and disintegrant. Its preparing process is also disclosed.

Description

Technical field [0001] The invention relates to a new anti-tuberculosis fast-slow-release compound drug, in particular to a fast-slow double-release preparation of the anti-tuberculosis compound rifampicin (isoniazid + rifampin). Background technique [0002] Currently, among global infectious diseases, tuberculosis has become the number one killer and the biggest cause of death. Regarding the fact that the tuberculosis epidemic is getting worse, the WHO declared to the world in 1993 that the world is in a state of tuberculosis emergency; March 24 every year is designated as World Tuberculosis Day; my country’s Ministry of Health also listed the original as a Class C infection in 1996 Tuberculosis under disease management has risen to category B management. At present, tuberculosis is re-epidemic and shows an increasingly serious trend. Generally speaking, there are several reasons: 1. The neglect of tuberculosis in various countries in the past 20 years and the relatively backwa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/496A61K31/4409A61P31/06
Inventor 余华陈新菊曾文丽郭晟肖小华利家平方铝朱令元
Owner 江西万基药物研究院药业有限责任公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com